
Join to View Full Profile
20 Duke Medicine CirDurham, NC 27710
Phone+1 919-668-5640
Fax+1 646-501-8904
Dr. Sulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2004 - 2008
Albert Einstein Medical CenterInternship, Transitional Year, 2003 - 2004
Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
NC State Medical License 2025 - 2026
NY State Medical License 2018 - 2026
TX State Medical License 2008 - 2025
PA State Medical License 2003 - 2004
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Hypofractionation of Gamma Knife Radiosurgery for Intracranial Meningiomas: A Retrospective Multicenter Study and Systematic Review of Literature.Ying Meng, Derek S Tsang, Kenneth Bernstein, Brandon Santhumayor, Elad Mashiach
Neurosurgery. 2025-10-27 - 1 citationsDual Immune Check Point Blockade in-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, Andrew E Sloan, Tony J C Wang
Journal of Clinical Oncology. 2025-09-20 - Outcomes of concurrent versus non-concurrent immune checkpoint inhibition with stereotactic radiosurgery for melanoma brain metastases.Allen Ye Fu, Kenneth Bernstein, Jeff Zhang, Joshua Silverman, Janice Mehnert
Journal of Neuro-Oncology. 2025-07-01
Journal Articles
- BCAT1 and miR-2504: Novel Methylome Signature Distinguishes spindle/desmoplastic Melanoma from Superficial Malignant Peripheral Nerve Sheath TumorErik P Sulman, Matija Snuderl, George Jour, Phyu P Aung, Nature
- A Co-Clinical Radiogenomic Validation Study - Conserved Magnetic Resonance Radiomic Appearance of Periostin Expressing Glioblastoma in Patients and Xenograft ModelsSanjay K Singh, Ashok J Kumar, Rivka R Colen, Gregory N Fuller, Frederick F Lang, Erik P Sulman, Clinical Cancer Research
- Cell Surface Notch Ligand DLL3 Is a Therapeutic Target in Isocitrate Dehydrogenase Mutant GliomaJohn G Golfinos, Daniel P Cahill, Erik P Sulman, David Zagzag, Clinical Cancer Research
Lectures
- Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for Glioblastoma2013 Annual Meeting, Chicago, Illinois, USA
- Predictive Molecular Biomarkers: Enriching Clinical Trial Populations for GlioblastomaAmerican Society of Clinical Oncology, 2013 Annual Meeting, Chicago, Illinois, USA
Press Mentions
- Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical ResearchOctober 29th, 2020
NYU Langone Health Launches New Molecular Assay to Identify Patients with Brain TumorsOctober 24th, 2019
How a Brain Tumor Taught Me to Embrace MyselfDecember 6th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









